Complex actions of sodium glucose transporter-2 inhibitors on lipids, calcific atherosclerosis, and bone density
{{output}}
Purpose of review: Inhibitors of sodium-glucose cotransporter-2 (SGLT2) lower renal glucose reabsorption and, thus, are used to treat patients with type 2 diabetes mellitus. Clinical trials coincidentally showed that SGLT2 inhibi... ...
